
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750

Income Statement
Earnings Waterfall
Jiang Zhong Pharmaceutical Co Ltd
Revenue
|
4.2B
CNY
|
Cost of Revenue
|
-1.5B
CNY
|
Gross Profit
|
2.7B
CNY
|
Operating Expenses
|
-1.7B
CNY
|
Operating Income
|
945.8m
CNY
|
Other Expenses
|
-192.7m
CNY
|
Net Income
|
753.2m
CNY
|
Income Statement
Jiang Zhong Pharmaceutical Co Ltd
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
2 952
N/A
|
2 834
-4%
|
2 757
-3%
|
2 763
+0%
|
2 664
-4%
|
2 597
-3%
|
2 455
-5%
|
2 150
-12%
|
1 805
-16%
|
1 562
-13%
|
1 510
-3%
|
1 569
+4%
|
1 778
+13%
|
1 747
-2%
|
1 778
+2%
|
1 764
-1%
|
1 731
-2%
|
1 755
+1%
|
1 832
+4%
|
2 001
+9%
|
2 167
+8%
|
2 449
+13%
|
2 437
0%
|
2 467
+1%
|
2 481
+1%
|
2 442
-2%
|
2 594
+6%
|
2 549
-2%
|
2 644
+4%
|
2 874
+9%
|
3 127
+9%
|
3 509
+12%
|
3 811
+9%
|
3 885
+2%
|
4 197
+8%
|
4 208
+0%
|
4 077
-3%
|
4 390
+8%
|
4 301
-2%
|
4 265
-1%
|
4 222
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1 559)
|
(1 377)
|
(1 352)
|
(1 352)
|
(1 345)
|
(1 326)
|
(1 119)
|
(886)
|
(650)
|
(455)
|
(501)
|
(531)
|
(594)
|
(537)
|
(586)
|
(592)
|
(586)
|
(576)
|
(646)
|
(693)
|
(760)
|
(820)
|
(868)
|
(897)
|
(903)
|
(848)
|
(944)
|
(923)
|
(955)
|
(1 026)
|
(1 140)
|
(1 291)
|
(1 391)
|
(1 384)
|
(1 528)
|
(1 500)
|
(1 452)
|
(1 532)
|
(1 548)
|
(1 524)
|
(1 532)
|
|
Gross Profit |
1 393
N/A
|
1 457
+5%
|
1 405
-4%
|
1 412
+0%
|
1 320
-7%
|
1 272
-4%
|
1 336
+5%
|
1 264
-5%
|
1 155
-9%
|
1 107
-4%
|
1 010
-9%
|
1 038
+3%
|
1 184
+14%
|
1 209
+2%
|
1 192
-1%
|
1 173
-2%
|
1 145
-2%
|
1 179
+3%
|
1 187
+1%
|
1 308
+10%
|
1 407
+8%
|
1 630
+16%
|
1 570
-4%
|
1 570
+0%
|
1 578
+1%
|
1 594
+1%
|
1 650
+4%
|
1 626
-1%
|
1 689
+4%
|
1 848
+9%
|
1 988
+8%
|
2 217
+12%
|
2 420
+9%
|
2 501
+3%
|
2 669
+7%
|
2 709
+1%
|
2 625
-3%
|
2 858
+9%
|
2 753
-4%
|
2 742
0%
|
2 690
-2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1 141)
|
(1 093)
|
(1 025)
|
(999)
|
(891)
|
(821)
|
(858)
|
(782)
|
(699)
|
(666)
|
(563)
|
(584)
|
(667)
|
(736)
|
(721)
|
(686)
|
(649)
|
(650)
|
(641)
|
(732)
|
(819)
|
(1 096)
|
(1 030)
|
(1 001)
|
(1 021)
|
(1 017)
|
(1 049)
|
(1 042)
|
(1 081)
|
(1 297)
|
(1 397)
|
(1 546)
|
(1 791)
|
(1 842)
|
(1 938)
|
(1 991)
|
(1 866)
|
(1 986)
|
(1 847)
|
(1 806)
|
(1 745)
|
|
Selling, General & Administrative |
(1 136)
|
(1 032)
|
(978)
|
(952)
|
(845)
|
(791)
|
(819)
|
(741)
|
(661)
|
(634)
|
(563)
|
(585)
|
(670)
|
(704)
|
(725)
|
(692)
|
(648)
|
(621)
|
(629)
|
(724)
|
(816)
|
(1 044)
|
(1 006)
|
(973)
|
(989)
|
(986)
|
(1 038)
|
(1 028)
|
(1 069)
|
(1 229)
|
(1 347)
|
(1 499)
|
(1 722)
|
(1 759)
|
(1 893)
|
(1 936)
|
(1 819)
|
(1 867)
|
(1 739)
|
(1 691)
|
(1 646)
|
|
Research & Development |
0
|
(39)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
(6)
|
(25)
|
(32)
|
(41)
|
(45)
|
(37)
|
(46)
|
(50)
|
(51)
|
(44)
|
(66)
|
(66)
|
(70)
|
(74)
|
(96)
|
(99)
|
(113)
|
(84)
|
(99)
|
(102)
|
(98)
|
(112)
|
(135)
|
(153)
|
(140)
|
|
Depreciation & Amortization |
0
|
(21)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(35)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(5)
|
(1)
|
(47)
|
(47)
|
(46)
|
13
|
(39)
|
(41)
|
(39)
|
7
|
(0)
|
1
|
3
|
7
|
4
|
7
|
5
|
16
|
20
|
33
|
42
|
24
|
22
|
22
|
19
|
48
|
54
|
51
|
58
|
48
|
47
|
52
|
43
|
45
|
54
|
47
|
51
|
50
|
27
|
38
|
42
|
|
Operating Income |
253
N/A
|
364
+44%
|
381
+5%
|
413
+8%
|
429
+4%
|
451
+5%
|
478
+6%
|
482
+1%
|
456
-5%
|
440
-3%
|
447
+2%
|
454
+2%
|
517
+14%
|
473
-8%
|
471
0%
|
487
+3%
|
496
+2%
|
529
+7%
|
546
+3%
|
577
+6%
|
589
+2%
|
533
-9%
|
540
+1%
|
569
+5%
|
557
-2%
|
577
+4%
|
601
+4%
|
584
-3%
|
608
+4%
|
551
-9%
|
591
+7%
|
672
+14%
|
628
-6%
|
659
+5%
|
732
+11%
|
718
-2%
|
759
+6%
|
872
+15%
|
906
+4%
|
936
+3%
|
946
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(30)
|
(34)
|
(35)
|
(34)
|
(33)
|
(28)
|
1
|
14
|
22
|
5
|
10
|
14
|
15
|
9
|
9
|
10
|
9
|
19
|
23
|
13
|
17
|
35
|
35
|
23
|
31
|
(3)
|
1
|
28
|
36
|
74
|
75
|
76
|
81
|
88
|
85
|
92
|
73
|
21
|
22
|
16
|
28
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
0
|
1
|
(0)
|
0
|
0
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
1
|
1
|
1
|
|
Gain/Loss on Disposition of Assets |
(0)
|
(0)
|
0
|
0
|
0
|
8
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
7
|
5
|
4
|
4
|
11
|
1
|
10
|
8
|
0
|
(1)
|
(8)
|
(10)
|
(12)
|
(10)
|
(4)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
0
|
(2)
|
(1)
|
(0)
|
(1)
|
6
|
6
|
6
|
4
|
(3)
|
(3)
|
(3)
|
(1)
|
5
|
9
|
9
|
10
|
5
|
(1)
|
2
|
(3)
|
|
Pre-Tax Income |
230
N/A
|
334
+46%
|
349
+4%
|
384
+10%
|
407
+6%
|
440
+8%
|
489
+11%
|
503
+3%
|
477
-5%
|
444
-7%
|
448
+1%
|
458
+2%
|
520
+13%
|
472
-9%
|
476
+1%
|
495
+4%
|
506
+2%
|
548
+8%
|
568
+4%
|
589
+4%
|
606
+3%
|
566
-7%
|
572
+1%
|
591
+3%
|
586
-1%
|
579
-1%
|
608
+5%
|
618
+2%
|
648
+5%
|
623
-4%
|
663
+6%
|
745
+12%
|
709
-5%
|
753
+6%
|
826
+10%
|
819
-1%
|
842
+3%
|
897
+7%
|
929
+4%
|
956
+3%
|
972
+2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(40)
|
(68)
|
(71)
|
(73)
|
(72)
|
(72)
|
(79)
|
(79)
|
(77)
|
(64)
|
(66)
|
(65)
|
(75)
|
(55)
|
(52)
|
(59)
|
(55)
|
(78)
|
(83)
|
(88)
|
(97)
|
(87)
|
(89)
|
(91)
|
(89)
|
(89)
|
(90)
|
(90)
|
(102)
|
(92)
|
(100)
|
(118)
|
(106)
|
(107)
|
(117)
|
(113)
|
(112)
|
(130)
|
(135)
|
(139)
|
(146)
|
|
Income from Continuing Operations |
190
|
267
|
279
|
311
|
335
|
368
|
410
|
423
|
399
|
380
|
381
|
394
|
445
|
418
|
425
|
436
|
451
|
470
|
485
|
501
|
509
|
479
|
483
|
499
|
498
|
490
|
518
|
528
|
546
|
531
|
562
|
628
|
603
|
646
|
709
|
705
|
731
|
767
|
793
|
817
|
826
|
|
Income to Minority Interest |
(2)
|
(2)
|
(4)
|
(3)
|
(3)
|
(1)
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(7)
|
(11)
|
(16)
|
(15)
|
(18)
|
(18)
|
(17)
|
(17)
|
(17)
|
(18)
|
(25)
|
(32)
|
(36)
|
(44)
|
(48)
|
(55)
|
(55)
|
(50)
|
(58)
|
(59)
|
(67)
|
(73)
|
|
Net Income (Common) |
188
N/A
|
265
+41%
|
275
+4%
|
308
+12%
|
332
+8%
|
367
+11%
|
411
+12%
|
424
+3%
|
400
-6%
|
380
-5%
|
381
+0%
|
394
+3%
|
445
+13%
|
418
-6%
|
425
+2%
|
436
+3%
|
451
+3%
|
470
+4%
|
481
+2%
|
494
+3%
|
498
+1%
|
464
-7%
|
468
+1%
|
482
+3%
|
480
0%
|
474
-1%
|
502
+6%
|
510
+2%
|
527
+3%
|
506
-4%
|
530
+5%
|
591
+12%
|
559
-6%
|
598
+7%
|
653
+9%
|
651
0%
|
681
+5%
|
708
+4%
|
734
+4%
|
750
+2%
|
753
+0%
|
|
EPS (Diluted) |
0.29
N/A
|
0.42
+45%
|
0.44
+5%
|
0.49
+11%
|
0.53
+8%
|
0.58
+9%
|
0.65
+12%
|
0.67
+3%
|
0.63
-6%
|
0.6
-5%
|
0.6
N/A
|
0.62
+3%
|
0.71
+15%
|
0.66
-7%
|
0.67
+2%
|
0.69
+3%
|
0.71
+3%
|
0.75
+6%
|
0.77
+3%
|
0.79
+3%
|
0.8
+1%
|
0.74
-8%
|
0.75
+1%
|
0.77
+3%
|
0.76
-1%
|
0.75
-1%
|
0.79
+5%
|
0.8
+1%
|
0.83
+4%
|
0.8
-4%
|
0.84
+5%
|
0.94
+12%
|
0.88
-6%
|
0.95
+8%
|
1.03
+8%
|
1.02
-1%
|
1.07
+5%
|
1.12
+5%
|
1.17
+4%
|
1.2
+3%
|
1.2
N/A
|